Study identifies new potential drug target for pneumonia

Researchers at Karolinska Institutet in Sweden report that a recently discovered inflammatory mediator, interleukin-26, appears to have an important role in pneumonia and contributes to the killing of bacteria. The study is published in the scientific journal Frontiers in Immunology.

source https://medicalxpress.com/news/2021-10-potential-drug-pneumonia.html